We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Breakthrough Implant Marks Paradigm Shift in Treatment of Gastroesophageal Reflux

By HospiMedica International staff writers
Posted on 31 May 2023
Print article
Image: RefluxStop treats acid reflux without affecting the food passageway (Photo courtesy of Implantica AG)
Image: RefluxStop treats acid reflux without affecting the food passageway (Photo courtesy of Implantica AG)

Acid reflux, a condition characterized by the regurgitation of the stomach's acid content into the esophagus, affects approximately 400 million individuals daily, making it the second-largest treatment field globally. This condition can progress into a chronic disease known as gastroesophageal reflux disease (GERD) when acid reflux episodes become frequent. Traditional surgical treatments have been associated with numerous complications, such as difficulties in swallowing and an inability to belch or vomit. This is largely due to these methods encircling the food passage to bolster the closing ring muscle. Now, a novel implant based on a unique invention offers a solution to acid reflux without interfering with the food passageway.

Implantica AG’s (Zug, Switzerland) RefluxStop is a CE-marked implant designed to prevent gastroesophageal reflux and could potentially revolutionize the treatment of acid reflux. Unlike drug therapy, RefluxStop not only manages acid reflux symptoms but also eliminates stomach fluid regurgitation. This innovative, non-active implant is positioned on the upper section of the stomach through laparoscopic (keyhole) surgery.

The RefluxStop device obstructs the reflux process, which is triggered by anatomical misalignment associated with abnormal fundus contractions that also involve fluid, along with sphincter relaxation. Furthermore, it acts as a mechanical barrier that prevents the lower esophageal sphincter (LES) from shifting into the thorax. With abdominal pressure, the LES can function normally. RefluxStop was granted CE mark approval based on a multi-center clinical study demonstrating the device's safety and efficacy in patients. The study suggests that RefluxStop leads to lower complication rates compared to existing surgical treatments. Recently, RefluxStop won the Medtop Tech Award for the most innovative medical device among all competitors.

"We thank Medtop for acknowledging Implantica's premier commercial product, RefluxStop, as the most innovative medical device for 2023," said Dr. Peter Forsell, CEO and founder of Implantica. "This is validation that RefluxStop truly is a breakthrough in treating acid reflux. RefluxStop is making strides in demonstrating outstanding clinical results, enabling Reflux experts to offer a unique therapeutic solution to help millions of patients with acid reflux around the world."

Related Links:
Implantica AG

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Supplier
12-Channel ECG
Transcutaneous Monitor
LED Light System

Print article


Critical Care

view channel
Image: Flexible thin-film electrodes placed directly on brain tissue have shown promise for diagnosis and treatment of epilepsy (Photo courtesy of Tokyo Tech)

Thin-Film Neural Electrodes Placed Directly on Brain Tissue Can Diagnose and Treat Epilepsy

Analyzing brain activity is crucial for diagnosing conditions like epilepsy and other mental health disorders. Among various methods, electroencephalography (EEG) is considered the least intrusive, using... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more


view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.